BACITRACIN ZINC - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bacitracin zinc and what is the scope of patent protection?
Bacitracin zinc
is the generic ingredient in sixteen branded drugs marketed by X Gen Pharms, Padagis Us, Casper Pharma Llc, Akorn, Bausch And Lomb, Pharmafair, Monarch Pharms, Combe, Pharmaderm, Dow Pharm, Naska, Glaxosmithkline, and Saptalis Pharms, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.There are eleven drug master file entries for bacitracin zinc.
Summary for BACITRACIN ZINC
US Patents: | 0 |
Tradenames: | 16 |
Applicants: | 13 |
NDAs: | 24 |
Drug Master File Entries: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 31 |
Patent Applications: | 54 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for BACITRACIN ZINC |
DailyMed Link: | BACITRACIN ZINC at DailyMed |
Recent Clinical Trials for BACITRACIN ZINC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ohio State University | N/A |
Cairo University | Early Phase 1 |
University of Turin, Italy | N/A |